Symposium 14: Prevention and management of cardiovascular disease in old age and frailty
Tracks
Track 6
Wednesday, July 15, 2026 |
11:15 AM - 1:15 PM |
Details
This symposium, led by the Geriatric Committee of the IUPHAR Clinical and Translational Section, highlights international, interdisciplinary innovations in the prevention and management of a wide range of cardiovascular diseases in older people, including those who are frail.
Prof Petrovic (clinical pharmacologist/geriatrician, Belgium), will discuss potentially inappropriate prescribing and adverse outcomes in older people with AF and multimorbidity from H2020 AFFIRMO trial. Dr Goyal (EMCR cardiologist, USA) will cover research and innovation to optimise medication regimens in older adults with heart failure, including deprescribing and N-of-1 trials. Prof Lindley (geriatrician/stroke physician, Australia), will highlight evidence-practice gaps in prevention and management of stroke in older people living with frailty. Dr Hopper (EMCR clinical pharmacologist, Australia) will provide insights from ASPREE and STAREE on prevention of cardiovascular disease in older people. Dr Nguyen (EMCR geriatrician/cardiologist, Vietnam/Australia) will describe the prevalence, management and outcomes of cardiovascular disease in Vietnam: the influence of frailty.
Speaker
Prof Mirko Petrovic
University of Gent
Potentially inappropriate prescribing and adverse health outcomes in older adults atrial fibrillation and multimorbidity: findings from the H2020 AFFIRMO trial
Biography
Mirko Petrovic, MD, PhD, tenured senior full professor of geriatrics and clinical pharmacology at Ghent University, Belgium, is a senior clinical researcher with extensive expertise in geriatric pharmacotherapy. He currently serves as the chairman of the Department of Internal Medicine and Paediatrics at the Faculty of Medicine and Health Sciences. Additionally, he is the President of the European Geriatric Medicine Society (EuGMS) and a member of the Royal Academy of Medicine of Belgium.
Dr Tu Nguyen
George Institute, UNSW
Sex differences in the impact of frailty on health outcomes in older adults with cardiometabolic disease: observational studies in Vietnam
Biography
Dr Tu Nguyen (MD PhD FESC FACC) is a physician with postgraduate training in geriatrics and cardiovascular medicine in Vietnam. She obtained a PhD in Cardiovascular Pharmacology/Epidemiology from the University of Sydney, Australia. She currently hold appointments as a Research Fellow at the George Institute for Global Health in Australia, Leadership Team Member of the Sydney Health Partners Geriatric Medicine Clinical Academic Group, and Adjunct Senior Lecturer at Sydney School Public Health. She is also Co-Lead of the Frailty and Cardiovascular Disease Research Theme at the Department of Geriatrics and Gerontology, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. She serves as an Associate Editor for the Australasian Journal on Ageing, and as an Associate Editor for the European Journal of Preventive Cardiology.
She has a research passion in geriatric cardiology, frailty and multimorbidity. Her work in frailty and cardiovascular disease has been cited by the 2016 ESC Guidelines for the Management of Atrial Fibrillation, the 2022 ADA/EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes, the 2022 ESC Consensus Document on Frailty in Cardiology, and the 2023 EHRA Expert Consensus Document on the Management of Arrhythmias in Frailty Syndrome.
Session chair
Parag Goyal
Weill Cornell Medical School
Sarah Hilmer
Kolling Institute, Royal North Shore Hospital, NSLHD and University of Sydney
